RxDoctor Payments Data

Stephanie Carmean, MD

Internal Medicine · Chicago, ILNPI 1932668753

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.1% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,788, 9.2 times the $194 reported in 2020. Among internal medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,670in general payments, 2019–2025

Across 158 payments — averaging $23.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$617
  • Johnson & Johnson$493
  • Novartis$347
  • UCB, Inc.$304
  • Lilly USA, LLC$275
  • Regeneron Healthcare Solutions, Inc.$245
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,38192%
  • Education$2898%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,670 in reported general payments places this provider in the 90th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois →

Medicare billing

Part B allowed, 2024
$354,835
Medicare patients
448
Services billed
3,943

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Unoready PenSecukinumab13$174,018
Dupixent PenDupilumab17$64,052
Clobetasol Propionate118$4,941
Fluorouracil31$2,852
Ketoconazole163$2,463
Tacrolimus19$2,008
Clindamycin Phosphate32$1,961
Doxycycline Monohydrate40$1,355
Doxycycline Hyclate30$1,314
Tretinoin17$1,196
Triamcinolone Acetonide100$1,094
Hydrocortisone51$943
Gentamicin Sulfate20$697
Mupirocin82$467
ValacyclovirValacyclovir Hcl12$286

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →